These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3106125)

  • 61. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen.
    Osorio RW; Ascher NL; Stock PG
    Transplantation; 1994 Mar; 57(6):783-8. PubMed ID: 8154021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
    Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation.
    Yamagami S; Tsuru T; Ohkawa T; Endo H; Isobe M
    Transplantation; 1999 Feb; 67(4):600-4. PubMed ID: 10071034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
    Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Weinberg DS; Reimann KA; Letvin NL; Waldmann TA; Kirkman RL
    Transplantation; 1989 Jan; 47(1):55-9. PubMed ID: 2643232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
    Kupiec-Weglinski JW; Heidecke CD; Araujo JL; Abbud-Filho M; Towpik E; Araneda D; Strom TB; Tilney NL
    Cell Immunol; 1985 Jun; 93(1):168-77. PubMed ID: 3158407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function.
    Kaufman DB; Morel P; Condie R; Field MJ; Rooney M; Tzardis P; Stock P; Sutherland DE
    Transplantation; 1991 Jan; 51(1):37-42. PubMed ID: 1987703
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Schellekens H; Jacques Y; Soulillou JP
    J Heart Lung Transplant; 1991; 10(3):424-30. PubMed ID: 1906747
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanisms of rat pancreatic islet allograft rejection.
    Charles MA; Sharma B; Dodson LE; Ownbey J; Noble S; Waldeck N; Brown G; True L; Nakane P; Suzuki M
    Diabetes Res; 1984 Jul; 1(2):95-103. PubMed ID: 6241544
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.
    Imagawa DK; Millis JM; Seu P; Olthoff KM; Hart J; Wasef E; Dempsey RA; Stephens S; Busuttil RW
    Transplantation; 1991 Jan; 51(1):57-62. PubMed ID: 1987706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blockade of 4-1BB/4-1BB ligand interactions prevents acute rejection in rat liver transplantation.
    Qin L; Guan HG; Zhou XJ; Yin J; Lan J; Qian HX
    Chin Med J (Engl); 2010 Jan; 123(2):212-5. PubMed ID: 20137373
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Passive enhancement of isolated pancreatic islet allografts.
    Finch DR; Morris PJ
    Transplantation; 1976 Nov; 22(5):508-12. PubMed ID: 136772
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phenotyping of lymphocytes following transplantation of allogeneic rat pancreatic islets into streptozotocin-diabetic recipients.
    Kuttler B; Volk HD; Kauert C; Diamantstein T; Hahn HJ
    Exp Clin Endocrinol; 1990 Feb; 95(1):64-9. PubMed ID: 2110525
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Importance of transplant site for prolongation of islet xenograft survival (rat to mouse) after low-temperature culture and cyclosporin A.
    Kamei T; Yasunami Y; Terasaka R; Konomi K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2693-4. PubMed ID: 2495670
    [No Abstract]   [Full Text] [Related]  

  • 76. Prolongation of renal allograft survival in the rat by pretreatment with donor antigen and cyclosporin A.
    Homan WP; Williams KA; Millard PR; Morris PJ
    Transplantation; 1981 Jun; 31(6):423-7. PubMed ID: 7020180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prolonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies.
    Kobayashi T; Harb G; Rayat GR
    Transplantation; 2005 Sep; 80(6):821-7. PubMed ID: 16210971
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of a rat kidney perfusion using the anti-MHC class II monoclonal antibody and reduced dose of 15-deoxyspergualine on the allogeneic graft survival.
    Oko A; Krzymański M; Deja A; Ulrichs K; Waaga AM; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):293-7. PubMed ID: 8744649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tissue culture reduces Ia antigen-bearing cells in rat islets and prolongs islet allograft survival.
    Rabinovitch A; Alejandro R; Noel J; Brunschwig JP; Ryan US
    Diabetes; 1982 Aug; 31 Suppl 4():48-54. PubMed ID: 6819964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The TheraCyte™ device protects against islet allograft rejection in immunized hosts.
    Kumagai-Braesch M; Jacobson S; Mori H; Jia X; Takahashi T; Wernerson A; Flodström-Tullberg M; Tibell A
    Cell Transplant; 2013; 22(7):1137-46. PubMed ID: 23043940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.